Dr. Jennifer Ledwell, Associate, Marks & Clerk to Speak at The Knowledge Group’s Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape LIVE Webcast
Dr. Jennifer Ledwell, Associate, Marks & Clerk’s Ottawa, Canada office will speak at its webcast entitled, “Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape” scheduled for October 1, 2019 from 12:00 pm to 2:00 pm ET.
- (1888PressRelease) September 17, 2019 - The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Dr. Jennifer Ledwell, Associate, Marks & Clerk’s Ottawa, Canada office will speak at its webcast entitled, “Obviousness-Type Double Patenting: Navigating the Ever-Evolving Landscape.” This event is scheduled for October 1, 2019 from 12:00 pm to 2:00 pm ET.
For further details, please visit: https://www.theknowledgegroup.org/webcasts/obviousness-type-double-patenting/
About Dr. Jennifer Ledwell
Jennifer’s patent practice is primarily in the areas of biotechnology, pharmaceuticals, and chemistry. She has been a registered Canadian Patent Agent since 2003 and has over 18 years of experience working with patents.
Jennifer’s enthusiasm for patents stems from her strong scientific background. Prior to becoming a patent agent, Jennifer obtained a Bachelor of Science in 1990 with honours (summa cum laude) in Biochemistry from the University of Ottawa. She also obtained a Ph.D. from Stanford University in Molecular and Cellular Physiology, where she used electrophysiological techniques and mutagenesis to study cooperative interactions in voltage-gated potassium channel proteins. Current researchers consider her work in this area to have been far-sighted and it is still cited favourably today. She then spent two years as a post-doctoral research fellow at Yale University, where she used transgenic mice to study the physiological role of a voltage-gated potassium channel protein expressed in the inner ear and the immune system.
About Marks & Clerk
Marks & Clerk is recognised as one of the world’s leading firms in intellectual property (IP) law. Through a global network of over 650 people worldwide including a qualified team of experienced patent and trademark associates, they are capable of offering a full spectrum of technical expertise on all aspects of intellectual property matters – patents, trademarks, designs and copyright. This includes obtaining protection worldwide, portfolio management, strategic advice, commercial advice, licensing, enforcement, clearance and searches, validity and infringement opinions, due diligence and litigation.
With their network of offices in Canada, United Kingdom (across eight locations), Europe and Asia, and long-established relationships with other leading IP firms around the world, they are able to provide consistent high quality, seamless and cost-effective service to their clients both domestically and globally.
Abstract
The emergence of new court rulings in the U.S. and Canada continues to shape the applicability and scope of the obviousness-type double patenting (ODP) doctrine, which is meant to prevent patentees from unjustly extending patent rights by owning multiple patents on the same invention. Recently, the U.S. Court of Appeals for the Federal Circuit issued two significant decisions - Novartis AG v. Ezra Ventures LLC and Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical Inc. - which provide guidance on when ODP does not invalidate patent term extensions (PTEs). In Canada, where there is no terminal disclaimer, upcoming changes to the Patent Rules will impact procedures commonly used to prevent double patenting.
Counsel to patent applicants and owners should be in the know of the recent court rulings and other developments involving ODP to better manage potential threats and opportunities regarding patent term and validity.
This LIVE Webcast produced by The Knowledge Group will provide patent practitioners with an in-depth analysis of the evolving ODP landscape in the USA and Canada. They will examine the implications of recent U.S. Court rulings in Ezra and Breckenridge and other ODP updates while offering insights on how to best protect a client’s interests from significant ODP issues in the U.S. and Canada.
Some of the major topics that will be covered in this course are:
• Recent Court Rulings:
o Novartis AG v. Ezra Ventures LLC
o Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical Inc.
• Implications of Recent Trends and Developments
• Managing Potential Threats and Opportunities
• Best Practices and Strategies
About The Knowledge Group
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam